|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/14 | |
| C07D 413/14 | |||
| C07D 403/04 | |||
| C07D 403/14 | |||
| C07D 413/04 | |||
| C07D 417/04 | |||
| C07D 417/14 | |||
| C07D 419/04 | |||
| C07D 419/14 | |||
| A61K 31/41 | |||
| A61P 25/00 |
| (11) | Number of the document | 2906553 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13805561.1 |
| Date of filing the European patent application | 2013-10-09 | |
| (97) | Date of publication of the European application | 2015-08-19 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2013/059233 |
| Date | 2013-10-09 |
| (87) | Number | WO 2014/057435 |
| Date | 2014-04-17 |
| (30) | Number | Date | Country code |
| 12188019 | 2012-10-10 | EP | |
| 13157809 | 2013-03-05 | EP |
| (72) |
BOLLI, Martin, CH
BOSS, Christoph, CH
BROTSCHI, Christine, CH
GUDE, Markus, CH
HEIDMANN, Bibia, CH
SIFFERLEN, Thierry, CH
WILLIAMS, Jodi T., CH
|
| (73) |
Idorsia Pharmaceuticals Ltd,
Hegenheimermattweg 91, 4123 Allschwil,
CH
|
| (54) | OREXIN RECEPTOR ANTAGONISTS WHICH ARE [ORTHO BI (HETERO )ARYL]-[2-(META BI (HETERO)ARYL)-PYRROLIDIN-1-YL]-METHANONE DERIVATIVES |
| OREXIN RECEPTOR ANTAGONISTS WHICH ARE [ORTHO BI (HETERO )ARYL]-[2-(META BI (HETERO)ARYL)-PYRROLIDIN-1-YL]-METHANONE DERIVATIVES |